Physician profile
Peter E Levesque
NPI 1235163783
$913.58
in general payments reported to CMS, 2019-2025
18 companies · $74.45 in 2025
The $74.45 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $74.67 · 2021: $144 · 2022: $191 · 2023: $104 · 2024: $44.62 · 2025: $74.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $222.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $228.45 | 2019-2023 | |
| Abbvie INC. | $128.83 | 2019-2023 | |
| Astellas Pharma US INC | $75.60 | 2019-2022 | |
| Coloplast Corp | $74.48 | 2019-2022 | |
| Richard Wolf Medical Instruments Corp. | $74.45 | 2025 | |
| Sumitomo Pharma America, INC. | $42.83 | 2023-2024 | Gemtesa |
| Janssen Biotech, INC. | $42.60 | 2019-2021 | |
| Allergan, INC. | $36.99 | 2020-2021 | |
| Rochester Medical Corporation | $36.73 | 2019-2021 | |
| Neotract INC. | $24.84 | 2019 | |
| Telix Pharmaceuticals | $22.59 | 2024 | Illuccix |
| Antares Pharma, INC. | $22.11 | 2023 | Xyosted, Tlando, Nocdurna |
| Myovant Sciences INC. | $19.86 | 2022 | |
| Acerus Pharmaceuticals Corporation | $19.62 | 2022 | |
| Janssen Scientific Affairs, LLC | $19.36 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15.89 | 2022 | |
| 180 Medical, INC. | $15.74 | 2019 | |
| Boston Scientific Corporation | $12.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Levesque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.